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Abstract 
The presence of a persistently patent arterial duct is common in premature neonates 
and may be associated with high morbidity. Early accurate diagnosis, assessment of 
the significance of the left to right shunt and prompt treatment are required to 
improve the outcome in this infant population. 
MeSH: Ductus Arteriosus, Patent, Infant, Premature, Echocardiography, 
transthoracic, Prostaglandins, Prostaglandin antagonists, Indomethacin 
The arterial duct is a vascular structure found in all normal fetuses. It is a 
continuation of the pulmonary trunk to the descending aorta with variable insertion, 
but most commonly opposite to the origin of the left subclavian artery. Right 
ventricular output preferentially flows along this low impedance circulation rather than 
through the higher impedance pulmonary circulation toward the descending aorta 
and back to the placenta. 
The patency of the arterial duct is ensured by the low oxygen content of fetal blood 
and the vasodilating action of the prostaglandins but is less sensitive (mainly 
prostaglandin E2), to those that are produced locally in the wall of the duct.1 After 
birth the lungs expand, the oxygen content of the blood raises and the lung 
prostaglandin catabolism is enhanced. Both contribute to normal ductal constriction 
and closure. The arterial duct closes functionally within the first 96 hours after birth in 
healthy term and preterm infants,2 whilst its anatomical closure takes place over a 
few weeks. 
The duct of the premature infant is more sensitive to the vasodilating action of the 
prostaglandins, but is less sensitive to the normal rise of partial pressure of oxygen 
that takes place after birth. This phenomenon depends on the gestational age of the 
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infant. The more immature the infant is the higher the partial pressure of oxygen that 
is required to initiate ductal constriction.3 In preterm baboons ductal muscular 
constriction produces less local tissue hypoxia, therefore permanent sealing of the 
lumen is delayed.4 
It is normal for preterm infants to have a patent arterial duct, but it is the degree of 
shunting through it that contributes to the morbidity (necrotising enterocolitis, 
hypotension) that is seen. However after birth, because the pulmonary vascular 
resistance remains relatively high, there is no significant left to right flow through the 
duct. Subsequently, as the pulmonary resistance falls, shunting may occur from left 
to right, from aorta to pulmonary artery. 
During the last years more premature infants survive. The additional use of surfactant 
in these infants improves lung compliance and leads to a rapid fall in pulmonary 
resistance. This favours earlier left to right shunting through the anatomically open 
duct.5 The incidence of patent arterial duct in sick premature neonates is inversely 
related to birth weight and varies according to the population studied and the 
diagnostic criteria used. In singleton infants born at 24-34 weeks and were exposed 
antenatally to a single or multiple doses of gluccocorticosteroids the incidence of 
medically treated patent arterial duct is 20% and 13% respectively.6 
 
Pathophysiology 
Blood flows from the descending aorta to the pulmonary trunk through the patent 
arterial duct. This leads to high pulmonary blood flow, high venous return to the left 
atrium and finally volume loading of the left heart. This causes dilation of the left 
atrium and ventricle and can lead to congestive heart failure due to the reduced 
myocardial reserves of the premature infant. As left atrial pressure increases, left to 
right shunting occurs at the atrial level through the patent oval foramen, which may 
reduce left heart volume loading. 
 
Clinical picture 
The following clinical signs of hyperdynamic circulation accompany the presence of a 
haemodynamically significant arterial duct: 
 The pathognomonic continuous machinery-like murmur of the patent 
arterial duct described in older infants and children is often not present. Most 
frequently a high parasternal systolic murmur is found on examination. No 
murmur may be heard on auscultation, in very immature neonates, especially 
when the duct is very large - the so-called “silent duct”.7 The murmur may be 
intermittent for several days depending on the oxygenation status of the 
infant. 
 Hyperdynamic precordium, because of volume loading of the left heart. 
 Bounding pulses in the peripheral arteries. 
 
Non-specific signs of left to right shunt and heart failure 
include 
 The rumbling diastolic murmur of increased mitral flow 
 Rhales on the auscultation of the lungs 
 Liver enlargement in the presence of heart failure 
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 Reduction of both systolic and diastolic blood pressure. High pulse 
pressure difference due to lowering of the peripheral resistance and diastolic 
blood pressure is more common in older infants and children.8 
 
Indirect clinical signs include 
 Failure to show improvement in respiratory status at a certain postnatal age 
 Respiratory instability and swinging in ventilatory requirements 
 Increase in oxygen requirement and carbon dioxide retention 
 Tachycardia and tachypnea 
 Bradycardias and apnoeas 
 Extreme sensitivity in small increases in fluid and sodium supplementation 
 
Diagnosis 
The electrocardiogram is not helpful. With sustained left to right shunting it may show 
signs of left ventricular hypertrophy and left atrial enlargement. The chest X-Ray may 
show enlarged cardiac silhouette and lung congestion. Echocardiography is the 
milestone of diagnosis, as it is more precise and accurate than clinical signs alone.9 It 
is also useful to evaluate myocardial function and exclude coexistent congenital heart 
disease. Cardiac catheterization is nowadays never done, considering the accuracy 
of diagnosis provided by echocardiography. 
 
Echocardiographic diagnosis 
The duct can be directly visualized using the “duct shot”, which is a modified high left 
parasternal short axis view of the heart on cross-sectional echocardiography. 
The flow through the duct into the pulmonary trunk and from the aortic insertion can 
be identified using color flow mapping. The minimal diameter of the color flow jet has 
been used as a surrogate for the assessment of ductal shunting.10 
In cases when the flow through the arterial duct cannot be directly recorded, the 
presence of disturbance of flow in the pulmonary artery on color or pulsed wave 
Doppler may be identified more easily. 
The following echocardiographic findings accompany the presence of a significant 
left to right shunt through a patent arterial duct:11 
1. Left atrial and ventricular dilation 
2. Bowing of the oval foramen flap to the right and additional left to right 
shunt at the atrial level 
3. Left atrium (in systole)/aorta (in diastole) ratio greater than 1.5:1, 
signifying a significant left to right shunt with left heart volume loading. 
4. Reversal of flow in the descending aorta on Pulsed Doppler with the 
sample volume positioned distally to the origin of the duct 
5. Minimal diameter of ductal color flow jet more than 1.5mm 
The direction of flow through the patent arterial duct depends upon the pressure 
gradient between pulmonary trunk and aorta. When pulmonary and systemic 
pressures are approximately equal, the flow becomes bi-directional. It occurs from 
right to left in systole and from left to right in diastole. When pulmonary pressure is 
suprasystemic shunting occurs from pulmonary artery to aorta throughout the cardiac 
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cycle. This is rare in the acute phase of hyaline membrane disease,13 while it is a 
common echocardiographic finding in severe neonatal Pulmonary Hypertension 
caused by meconium aspiration, congenital diaphragmatic hernia or septicemia.14 
 
Conditions to be considered 
1. Duct dependent lesions  
Right sided 
 Severe pulmonary stenosis 
 Pulmonary atresia/ventricular septal defect 
 Absent right connection (tricuspid atresia) 
Left sided 
 Aortic stenosis or atresia 
 Mitral stenosis or atresia 
2. Left to right shunts  
 Vein of Gallen aneurysm with large left to right shunt and right heart 
volume overloading 
 Coronary arteriovenous fistula with pulmonary atresia/ventricular septal 
defect 
 Aortopulmonary window (rarely) 
3. Aggravation of chronic lung disease  
 
Complications 
The presence of a significant left to right shunt through a patent arterial duct may 
interfere with systemic organ perfusion15 because of a reduction or absence of end-
diastolic flow. The consequences are inadequate blood flow to the central nervous 
system,16 the kidneys and the gastrointestinal tract15 and therefore increased risk for 
intraventricular haemorrhage, renal dysfunction, aggravation of heart failure and 
necrotising enterocolitis. In contrast, the lungs are overperfused, which is associated 
with a higher incidence of pulmonary haemorrhage17 and is considered a risk factor 
for bronchopulmonary dysplasia.18 
 
Treatment 
This includes: 
1. Moderate fluid restriction 
2. Adequate tissue oxygenation using the appropriate ventilatory support 
3. Maintenance of a satisfactory haemoglobin level 
4. Cautious use of diuretics 
5. Provision of adequate nutrient supplementation 
6. Careful enteral feeding preferably using maternal breast milk 
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Specific pharmacologic treatment  
The drug that is used almost exclusively is indomethacin, which is a potent inhibitor 
of prostaglandin synthesis. Indomethacin has been used prophylactically in the first 
hours after birth.19 The usual approach is the administration of Indomethacin either 
after the infant develops any clinical sign consistent with a patent arterial duct, 
usually a murmur (early symptomatic) or when the infant starts to show signs of 
cardiovascular compromise (late symptomatic).20 In extremely premature infants 
clinical deterioration often precedes the presence of a murmur. The development of a 
murmur may indicate a small closing duct and is not an indication for treatment. 
There are several protocols of indomethacin administration. A more prolonged 
course of six doses does not produce more side effects and has lower relapse rate.21 
After completion of the dose schedule the duct may reopen22 and then a second 
therapeutic trial of indomethacin may be attempted. Indomethacin is ineffective for 
the closure of the patent arterial duct in infants of advanced postnatal age.23 The duct 
of the term neonate is not sensitive in prostaglandins and therefore Indomethacin is 
not given in term infants with patent arterial duct. 
Ibuprofen is another potent inhibitor of Prostaglandin synthesis that has been used in 
premature infants. It is considered as efficacious as indomethacin and has been 
shown to have fewer renal side effects.24 While indomethacin administration causes 
reduction of cerebral blood flow, cerebral blood volume and cerebral oxygen delivery 
as assessed by near infrared spectroscopy, ibuprofen has no adverse effects on 
cerebral haemodynamics and may play a protective role against the development of 
cerebral injury in preterm infants with patent arterial duct.25 The side effects of 
Indomethacin include renal dysfunction26 with sodium and fluid retention, impairment 
of platelet aggregation and neutrophil function and gastrointestinal haemorhage or 
perforation.27 
Surgical treatment  
In cases of indomethacin failure, contraindication or discontinuation because of 
severe adverse effects, surgical closure of a haemodynamically significant duct 
should be considered. In neonates the usual technique is duct ligation using a 
transthoracic or thoracoscopic approach.28 The transdermal closure of a patent 
arterial duct via an occluding device is a popular procedure for older children and 
adults but is still rarely considered in neonates29 due to its potential to harm the small 
femoral artery.30 The surgical closure of a patent arterial duct can be accomplished 
with minimal mortality in the neonatal period. 
 
Maintenance of ductal patency 
The maintenance of the patency of the ductus arteriosus may be crucial when 
considering neonates with certain types of congenital heart disease, in which the flow 
through the duct is the only way to support systemic or pulmonary circulation.31 After 
birth despite the deficient arterial oxygenation the arterial duct constricts and this 
causes rapid deterioration and severe cyanosis. Continuous infusion of Prostaglandin 
E1 or E2 maintains ductal patency until the infant is transported safely to a 
cardiothoracic unit for reparative or palliative surgery. Examples of such congenital 
heart disease are cyanotic lesions (transposition complexes, critical pulmonary 
stenosis or atresia, Tetralogy of Fallot, tricuspid atresia) or certain critical forms of left 
ventricular outflow obstruction (coarctation of the aorta, interruption of the aortic arch, 
hypoplastic left heart syndrome). 
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Figure 1 The “ice-hockey stick” appearance of the ductal arch in a 20-week normal 
fetus 
 
 
 
 
 
Figure 2 The “3 vessel view” in a 20-week fetus. The ascending aorta, the arterial 
duct and the superior caval vein are seen via a high mediastinal transverse cut 
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Figure 3 Magnetic resonance imaging of the thorax showing a very large patent 
arterial duct in the same infant. The image is equivalent to the “3 vessel view” seen 
on fetal echocardiography (figure 2 above) 
 
 
Figure 4 Pulsed wave Doppler of the arterial duct in a normal 20-week fetus 
 
 
Figure 7 When the arterial duct is widely patent and unrestrictive the whole ductal 
arch, as present in fetal life, may be seen on subcostal short axis view 
 
 
AA Karatza, DV Azzopardi, and HM Gardiner. The persistently patent arterial duct in the premature 
infant. Images Paediatr Cardiol. 2001 Jan-Mar; 3(1): 4–17.  
 11 
Figure 9 The “3-legged stool” view illustrates the right and left pulmonary branch 
arteries and the arterial duct seen from a high left parasternal short axis view (the 
“ductal cut”) 
 
 
Figure 11 Normal pulsed wave Doppler of pulmonary artery at the valvular level. The flow is laminar 
and less than 1 m/s 
 
 
Figure 12 Pulsed wave Doppler of the pulmonary trunk showing a chaotic pattern. 
The disturbance of flow in diastole is due to the haemodynamically significant duct 
shunting from left to right 
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Figure 13 Pulsed wave Doppler of the arterial duct at a velocity of 2.65m/s in systole. 
Flow is from left to right throughout the cardiac cycle 
 
 
Figure 14 Apical 4-chamber view showing left heart dilatation and bowing of the oval 
foramen flap to the right 
 
 
Figure 15 Parasternal long axis view of the heart in the same infant showing left atrial 
and ventricular dilation - the left atrial antero-posterior dimensions are greater than 
the aortic root dimensions 
 
 
Figure 16 Magnetic resonance imaging of the thorax showing left heart volume 
loading in a premature infant with a significant shunt through the arterial duct 
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Figure 17 M-mode through left atrium and aortic valve on left parasternal long axis 
 
 
Figure 18 M-mode in the short axis in the same infant as in figure17 on right 
 
 
Figure 19 Pulsed wave Doppler of descending aorta. The diastolic flow is prograde 
when the sample volume is placed centrally and retrograde when the sample volume 
is placed distally to the aortic insertion of the arterial duct 
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Figure 21 Pure right to left flow through the arterial duct in a neonate with severe 
pulmonary hypertension and a congenital diaphragmatic hernia 
 
 
 
 
 
 
Figure 22 After transfer to a high frequency oscillatory ventilator and treatment with 
inhaled Nitric Oxide the ductal Doppler becomes bi-directional (right to left in systole 
and left to right in diastole) in this same infant 
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Figure 24 Absence of end diastolic flow in the celiac artery compatible with “ductal 
steal” in a premature infant with necrotising enterocolitis and renal failure due to a 
significant left to right shunt through the arterial duct 
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